Filing Flows › Marimed (MRMD) › Q4 2024
Marimed (MRMD) Q4 2024 earnings results (fourth quarter 2024)
10-K filed Mar 6, 2025
Marimed (MRMD) reported revenue of $38.9M for the fourth quarter 2024 (Q4 2024), +0.1% from a year earlier and -4% from the quarter before. Operating margin was -3.6%, net loss $8.5M (21.8% of revenue).
Marimed, Q4 2024: revenue $38.9M (+0.1% year over year), operating margin -3.6%, net loss $8.5M, operating cash flow −$413K. The chart follows the revenue to costs, profit and cash.
| Q4 2024 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $38.9M | -4% | +0.1% |
| Operating profit | −$1.4M | — | — |
| Net earnings | −$8.5M | — | — |
| Operating cash flow | −$413K | — | — |
What changed
Revenue was $38.9M in Q4 2024, roughly flat year over year and down 4% from the previous quarter.
Gross margin was 32.5%, down 12.0 points from a year earlier. Operating costs exceeded revenue by $1.4M, an operating margin of -3.6%. Operating expenses fell 6% while revenue was flat. The quarter ended with a net loss of $8.5M, wider than the previous quarter's $1.0M loss.
Operating cash flow was −$413K. Non-cash charges added back $2.2M of depreciation and amortization and $278K of share-based compensation. Working capital and other items added $5.7M. Capital expenditures of $1.1M exceeded it, leaving free cash flow of −$1.5M.
Questions
What was Marimed's revenue in the fourth quarter 2024?
Marimed (MRMD) reported revenue of $38.9M for the fourth quarter 2024 (Q4 2024), +0.1% from a year earlier and -4% from the quarter before.
Was Marimed profitable in the fourth quarter 2024?
Operating loss was $1.4M (-3.6% of revenue) and net loss $8.5M.
Source: Marimed 10-K on SEC EDGAR.